Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bank of America Corp (BAC) Stock Teeters on Edge As Court Hearing Proceeds

Shares of Bank of America Corp (NYSE:BAC) are marginally higher today as investors anxiously await the conclusion of a critical hearing in New York state court. Roughly halfway through the trading session, it’s trading up by 0.22%.

There’s little doubt about the significance of this case for Bank of America Corp (NYSE:BAC) and its shareholders. Stemming from an $8.5 billion settlement that the bank entered into in 2011 with investors in Countrywide-issued mortgage-backed securities, a failure to attain the sought-after judicial approval will expose the nation’s second largest bank by assets to an untold amount of additional liability. To date, according to The Wall Street Journal, it’s already spent nearly $50 billion on legal costs tied to the financial crisis.

Bank of America Corp (NYSE:BAC)

As a mortgage-finance litigator told Bloomberg News, “The settlement is the centerpiece of the strategy to resolving Countrywide’s mortgage liability. It’s imperative they get this approved or there’s going to be a lot more pain down the road.”

The parties opposed to the settlement, including insurance giant American International Group Inc (NYSE:AIG), argue that it amounts to a “pennies-on-the-dollar bargain” for the bank because claims related to the underlying securities could eventually exceed $100 billion. They also argue that The Bank of New York Mellon Corporation (NYSE:BK), which served as trustee for the securities at issue, acted in bad faith by entering into the settlement, and as a result, the deal should not be given a judicial stamp of approval.

In response, Bank of America Corp (NYSE:BAC)’s attorneys purport that American International Group Inc (NYSE:AIG) is simply using the case to gain leverage in separate litigation between the parties. The fact that most other major objectors to the settlement, including the attorney generals from New York and Delaware, have since abandoned their complaints adds credibility to this position. The parties that remain in opposition are nothing more than a “vocal minority,” said those in favor of the deal.

The group of investors who lined up to settle in the first place reads like a Who’s Who list of Wall Street powerhouses. Among them are the asset-management giant BlackRock, Inc. (NYSE:BLK), Goldman Sachs Group, Inc. (NYSE:GS), and the insurer Metlife Inc (NYSE:MET). “When no other trustee [had] recovered [losses] for investors, it recovered $8.5 billion,” said an attorney for The Bank of New York Mellon Corporation (NYSE:BK). As a result, “The choice was made in good faith.”

I’ve noted on multiple occasions over the past few months that this case will be one of the principal catalysts for Bank of America Corp (NYSE:BAC)’s stock this year. If the bank is able to put this matter behind it, it’s reasonable to conclude that its shares will respond in kind. But if it isn’t, well, you do the math.

The article Bank of America Stock Teeters on Edge As Court Hearing Proceeds originally appeared on and is written by John Maxfield.

John Maxfield owns shares of Bank of America Corp (NYSE:BAC). The Motley Fool recommends American International Group (NYSE:AIG), BlackRock, Inc. (NYSE:BLK), and Goldman Sachs Group, Inc. (NYSE:GS). The Motley Fool owns shares of American International Group and Bank of America and has the following options: Long Jan 2014 $25 Calls on American International Group.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!